09/18/23 4:05 PMNasdaq : TELA conferencesacquisitionlow floatTELA Bio to Participate in the Gilmartin Group Emerging Growth Company ShowcaseTELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's ownRHEA-AIneutral
08/16/23 7:00 AMNasdaq : TELA low floatTELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive SurgeryTELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomesRHEA-AIneutral
08/09/23 4:03 PMNasdaq : TELA earningslow floatTELA Bio Reports Second Quarter 2023 Financial ResultsTELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's ownRHEA-AIneutral
08/04/23 4:02 PMNasdaq : TELA low floatTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of theRHEA-AIvery positive
07/26/23 7:00 AMNasdaq : TELA earningslow floatTELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth ConferenceTELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of theRHEA-AIneutral
06/15/23 7:00 AMNasdaq : TELA low floatNew Survey Finds Strong Consumer Preference for More Natural Hernia Repair OptionsTELA Bio, Inc . (NASDAQ: TELA), aRHEA-AIneutral
05/25/23 7:00 AMNasdaq : TELA conferenceslow floatTELA Bio to Participate in the Jefferies Global Healthcare ConferenceTELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy,RHEA-AIneutral
05/19/23 7:00 AMNasdaq : TELA low floatTELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver LabTELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes byRHEA-AIneutral
05/11/23 4:02 PMNasdaq : TELA earningslow floatTELA Bio Reports First Quarter 2023 Financial ResultsTELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's ownRHEA-AIneutral
05/08/23 4:30 PMNasdaq : TELA low floatTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of theRHEA-AIvery positive